The transaction aims to reconstruct the landscape of pharmaceutical services with a new value-driven model.
The transaction aims to reconstruct the landscape of pharmaceutical services with a new value-driven model.
Global law firm Sidley Austin advises Digital Health Company Waltz Health on a merger with Eversana, an independent provider of global services in the life sciences sector. The merger is set up to combine Waltz Health's digital platform with Eversana's Pharmaceutical and Biotech services to form more opportunities to deliver low-cost medicines.
Advising the merger, the Sidley team, based in the company's Chicago office, included M&A partner Gary Gaestman, M&A senior managing associate Jeff Wyson, and M&A associate Suzanne Nails.
The purpose of the merger is to create a unified healthcare platform that transforms drug commercialization and patient access by linking life science directly to payers and patients. This strategy hopes to accelerate access to drugs across the healthcare system, improve affordability, and translate drug value.
Under the agreement, Waltz Health's co-founder and CEO will continue as CEO of the United organization, with former CEO of Eversana Jim Lang joining as executive officer.
“We've been working hard to get the most out of our business,” said co-founder and CEO of Waltz Health Mark Thierer. “This is a crucial moment for the healthcare industry. By combining Eversana's Pharma services with Waltz's technology-enabled payer solutions, we create a unified platform that connects life science innovation directly to organizations and individuals. Steps.”
